BARCLAYS PLC - ELEVEN BIOTHERAPEUTICS INC ownership

ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 28 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 16.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ELEVEN BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2018$01
-98.7%
0.00%
Q3 2017$076
+484.6%
0.00%
Q4 2016$0
-100.0%
13
-91.0%
0.00%
Q1 2015$2,000
-33.3%
145
-44.4%
0.00%
Q4 2014$3,000
+50.0%
261
+72.8%
0.00%
Q3 2014$2,000
-60.0%
151
-61.6%
0.00%
Q2 2014$5,000
+150.0%
393
+216.9%
0.00%
Q1 2014$2,0001240.00%
Other shareholders
ELEVEN BIOTHERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 4,841,591$78,579,00013.93%
Flagship Ventures 2007 General Partner LLC 1,907,008$30,951,00013.58%
Broadfin Capital, LLC 861,933$13,989,0001.36%
NJ State Employees Deferred Compensation Plan 25,000$406,0000.08%
SECTORAL ASSET MANAGEMENT INC 50,000$812,0000.03%
TCW GROUP INC 105,550$1,713,0000.01%
FRANKLIN RESOURCES INC 938,100$15,225,0000.01%
State of New Jersey Common Pension Fund A 75,000$1,217,0000.01%
FMR LLC 1,614,715$26,206,0000.00%
PRINCIPAL FINANCIAL GROUP INC 95,300$1,547,0000.00%
View complete list of ELEVEN BIOTHERAPEUTICS INC shareholders